Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Mol Sci. 2012;13(6):6679-97. doi: 10.3390/ijms13066679. Epub 2012 Jun 1.

Intravascular targets for molecular contrast-enhanced ultrasound imaging.

Author information

1
MI Lab, Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim N-7006, Norway; E-Mail: ingrid.s.gribbestad@ntnu.no.

Abstract

Molecular targeting of contrast agents for ultrasound imaging is emerging as a new medical imaging modality. It combines advances in ultrasound technology with principles of molecular imaging, thereby allowing non-invasive assessment of biological processes in vivo. Preclinical studies have shown that microbubbles, which provide contrast during ultrasound imaging, can be targeted to specific molecular markers. These microbubbles accumulate in tissue with target (over) expression, thereby significantly increasing the ultrasound signal. This concept offers safe and low-cost imaging with high spatial resolution and sensitivity. It is therefore considered to have great potential in cancer imaging, and early-phase clinical trials are ongoing. In this review, we summarize the current literature on targets that have been successfully imaged in preclinical models using molecularly targeted ultrasound contrast agents. Based on preclinical experience, we discuss the potential clinical utility of targeted microbubbles.

KEYWORDS:

angiogenesis; cancer; microbubbles; molecular imaging; targeted contrast agents; ultrasound imaging

PMID:
22837657
PMCID:
PMC3397489
DOI:
10.3390/ijms13066679
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
    Loading ...
    Support Center